Search Results 8721-8730 of 40131 for oral
Patients must not be taking oral glucocorticoids at the time of registration. Patients must not be planning to receive concomitant biologic therapy ...
Patient is unable to swallow or keep down oral medication. Patients at the National Cancer Institute (NCI) site and other selected centers who are willing ...
Known central nervous system (CNS) involvement with AML. Gastrointestinal (GI) tract disease that causes an inability to take oral medications, malabsorption ...
Inability to swallow or tolerate oral medication. Has a history or current evidence of any condition, therapy, or laboratory abnormality that, in the ...
inability to take oral medication 2. malabsorption syndromes 3. requirement for intravenous alimentation 8. Any active bleeding excluding hemorrhoidal or ...
WOCBP taking oral contraceptives (OCs) also have to use one barrier method. Exclusion Criteria: 1. Prebronchodilator Forced Expiratory Volume in 1 second ...
(7) are willing to complete an Alere™ iScreen oral swab test to biochemically confirm self-reported smoking status with a positive test result for smoking as ...
Mayo Clinic Q&A: Understanding surgical options for oral cancer featured image. Cancer. Mayo Clinic Q&A: Understanding surgical options for oral cancer. Mayo ...
Patients who received oral bisphosphonate within ≤ 12 weeks, IV zoledronic acid (Reclast) ≤ 52 weeks, or denosumab ≤ 24 weeks will also be excluded.
Patients with mild claustrophobia are eligible and have the option to take 1mg oral Lorazepam prior to the MRI, if needed;; Allergy to gadolinium-containing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!